A Statewide Multi-Institutional Study of Asymptomatic Pretreatment Testing of Radiation Therapy Patients for SARS-CoV-2 in a High-Incidence Region of the United States

20217 citationsJournal Articlegold Open Access

Authors

Chirag Modi · Rutgers, The State University of New Jersey

Anthony E. Dragun · Cooper University Hospital

Clarissa F. Henson · Trinitas Regional Medical Center

Sheena Jain · Holy Redeemer

Stuti Ahlawat · Cooper University Hospital

Gary Eastwick · Cooper University Hospital

Gregory J. Kubicek

Abstract

Broad-based pretreatment asymptomatic testing of radiation oncology patients for SARS-CoV-2 is of limited value, even in a high-incidence region. Future strategies may include focused risk-stratified asymptomatic testing.

Topics & Keywords

COVID-19 and healthcare impacts COVID-19 Clinical Research Studies Infection Control and Ventilation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Advances in Radiation Oncology

Volume 6, Issue 4, pp. 100704-100704

DOI: 10.1016/j.adro.2021.100704

Field-Weighted Citation Impact: 0.63